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Abstract
Background: Chronic venous insufficiency, in its final stage can cause venous ulcers. Venous ulcers have a prevalence
of 0.5 % to 0.8 % in the general population, and increases starting at 60 years of age. This condition often causes
increased dependency in affected individuals, as well as a perceived reduced quality of life and family overload.
Local Treating chronic venous ulcers has 2 components: topically healing the ulcer and controlling the venous
insufficiency. There is evidence that compressive therapy favours the healing process of venous ulcers. The
studies we have found suggest that the use of multilayer bandage systems is more effective than the use of
bandages with a single component, these are mostly using in Spain. Multilayer compression bandages with 2
layers are equally effective in the healing process of chronic venous ulcers as 4-layer bandages and are better
tolerated and preferenced by patients. More studies are needed to specifically compare the 2-layer bandages
systems in the settings where these patients are usually treated.
Method/design: Randomised, controlled, parallel, multicentre clinical trial, with 12 weeks of follow-up and blind
evaluation of the response variable.
The objective is to assess the efficacy of multilayer compression bandages (2 layers) compared with crepe bandages,
based on the incidence of healed venous ulcers in individuals treated in primary care nursing consultations, at 12 weeks
of follow-up.
The study will include 216 individuals (108 per branch) with venous ulcers treated in primary care nursing consultations.
The primary endpoint is complete healing at 12 weeks of follow-up. The secondary endpoints are the degree of healing
(Resvech.2), quality of life (CCVUQ-e), adverse reactions related to the healing process. Prognosis and demographic
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variables are also recorder.
Effectiveness analysis using Kaplan-Meier curves, a log-rank test and a Cox regression analysis. The analysis was performed
by intention to treat.
Discussion: The study results can contribute to improving the care and quality of life of patients with venous ulcers,
decreasing healing times and healthcare expenditure and contributing to the consistent treatment of these lesions.
Trial registration: This study has been recorded in the Clinical Trials.gov site with the code NCT02364921.
17 February 2015.
Keywords: Venous ulcer, Compression bandage, Wound healing, Nursing, Primary health care, Quality of life
Background
Aging and chronicity
Spain, as with other developed countries, is experiencing
a progressive ageing of the population (according to the
National Institute of Statistics). In 2052, the over-64 age
group increased by 7.2 million, accounting for 37 % of
the total population [1], contributing to an increase in
chronic diseases, including chronic venous insufficiency.
In chronic venous insufficiency, the venous system of
the legs is ineffective in performing venous return, and
there is venous reflux due to valve failure, physical inactiv-
ity and cardiovascular problems, which lead to an increase
in pressure within the veins and venous hypertension.
Chronic venous insufficiency covers a series of signs
and symptoms including varicose veins, varicules, oedema,
skin lesions and ulcers.
The DETECT-IVC study conducted in Spain found
that 71 % of individuals in primary care consultations
had some sign or symptom related to chronic venous in-
sufficiency [2].
Venous ulcers. Prevalence and repercussion of the
problem
Venous ulcers are lesions skin loss that rest on the skin
affected by stasis dermatitis, secondary to severe chronic
venous insufficiency [3]. They are mainly located in the
internal lateral area of the distal third of the leg. To
diagnose this condition, is necessary a physical examin-
ation to confirm the presence of tibial pulses and/or a
pressure gradient in the feet >60 mmHg and/or an ankle
brachial index >0.8 to rule out an arterial origin [4].
Ambulatory venous hypertension represents the start
of the pathophysiology of venous ulcers. The most com-
mon trigger for ulceration is trauma on the preulcerative
lesions; however, the ulcers often start spontaneously on
the lesions [5].
Ulcers of venous aetiology constitute between 75 and
80 % of all ulcers. They have a prevalence of 0.5 % to
0.8 % in the general population and an incidence of
between 2 and 5 new cases per thousand individuals per
year [4]. The female to male ratio is 3:1, and increases
starting at 60 years of age [5].
The DETECT-IVC study in Spain [2] showed that
2.5 % of individuals in primary care consultations have
venous ulcers. This rate increases for women and the
elderly; 2 % of patients were hospitalised and 2.5 % took
time off from work.
The median healing time for chronic venous ulcers var-
ies between 75 and 90 days [6]. Half of all healed ulcers
recur at 12 months of healing. Pre-existing skin disorders
are a risk factor in the incidence of new relapses [5, 6].
These ulcers have abundant exudate, are often foul
smelling, can get infected and cause moderate pain,
which coupled with slow healing and frequent relapses
affect the quality of life of patients with these ulcers [7].
Treatment of venous ulcers. Compression bandages
Treating chronic venous ulcers requires a comprehensive
approach for the patient, by treating the aetiological fac-
tors that determine their evolution, such as venous insuffi-
ciency, diet, physical inactivity and postural measures.
Local treatment has 2 components: topically healing the
ulcer and controlling the venous insufficiency through the
use of compressive therapy.
Evidence suggests that the wound should be treated
with moist wound healing, with dressings to control the
exudate and perilesional skin moisturising [8].
There is evidence that compressive therapy favours
the healing process of venous ulcers. Borges et al., in a
systematic review of 33 primary studies and 2 meta-
analyses that included more than 1000 patients, con-
cluded that compressive therapy increases the healing
rate of venous ulcers [8]. O’Meara S et al. performed a
systematic review to compare the effectiveness of using
some type of compression bandages versus not using
any pressure in the healing of venous ulcers and
compared the effectiveness of various types of compres-
sion. The authors included 48 clinical trials with 4321
patients and concluded that compressive therapy
contributes to improving the flow of venous return,
decreases oedema and pain and favours the healing
process of venous ulcers [9].
There are various types of compression bandages.
They are classified according to the type of material
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(elastic/inelastic), degree of pressure (light, medium,
high) and number of layers (single layer/multilayer) [10].
The light compression elastic single-layer bandages and
the crepe bandage offer low pressure (15–20 mmHg for
the ankle). Multilayer bandages of 2, 3 or 4 layers can
combine elastic or inelastic components, reaching a
pressure of 40 mmHg at the ankle.
Advantages and disadvantages of the various types of
compression
The single-layer elastic bandages with light compression
maintain the necessary pressure level for 1 h, do not
control the exudate and can result in overpressure when
applying them and are therefore considered fixing ban-
dages [11, 12].
Multilayer bandages are effective both at rest and in
motion, they reduce the calibre of superficial and deep
veins, promote venous flow, reduce oedema, improve
the effect of the muscle pump of the lower legs and re-
duce orthostatic flow, residual volume and venous pres-
sure by improving the operation of venous valves [13].
Various studies have compared the efficacy of the dif-
ferent compression therapy systems in the healing of
chronic venous ulcers. O’Meara et al. performed a sys-
tematic review to compare the efficacy of 2 types of
compression bandages: multilayer bandages with 4
layers and short-stretch bandage. The authors included
5 clinical trials with 797 patients. They concluded that 4-
layer compression bandages are associated with a shorter
healing time. The authors recommended performing more
studies to compare the compression bandage systems,
using a system to blind the assessment of the response
variables [6].
Another study compared multilayer compression
bandages with 2 and 4 layers in terms of the pressure
achieved under the bandages and patient tolerance. The
study found no differences in the pressure achieved by
the 2 types of compression, but the 2-layer compression
bandage was better tolerated by the patients [14].
Moffatt et al. compared the complete healing rate at
8 weeks of follow-up, the quality of life and the patients’
preferences when using 2 types of compression bandages
(2 and 4-layer). The authors found no differences in the
complete healing rate; however, the overall quality of life
score and the preferences were significantly higher for
patients who used the 2-layer bandages [15].
It has been estimated that treating venous ulcers
generates high direct and indirect costs, increased
consultations in primary care and hospitalisations.
Topical and systemic treatments, represents approxi-
mately 2 % of the healthcare expenditure in Spain and
neighbouring countries [2].
Published literature suggest that the use of multilayer
bandage systems is more effective than the use of
bandages with a single component, although the major-
ity of the studies included 4-layer bandages. Moreover,
multilayer compression bandages with 2 layers are
equally effective in the healing process of chronic ven-
ous ulcers as 4-layer bandages and are better tolerated
by patients who express a preference for the 2-layer
bandages [15].
More studies are needed to specifically compare the
2-layer bandages systems in the settings where these
patients are usually treated, using blinding techniques
to assess the response variable.
In our region, light compression single-layer elastic
bandages (crepe bandages) are commonly used. We are
not aware of any study in Spain that has specifically
compared the effectiveness of 2-layer compression ban-
dages versus the single-layer elastic light compression
bandages commonly used in health centres.
We propose this study to compare the effectiveness of
2-layer compression bandages versus crepe bandages in
the healing of venous ulcers and determine how they
affect the quality of life of individuals with this problem.
Aim
The aim of this study is to assess whether multilayer com-
pression bandages with 2 layers are more effective than
crepe bandages in the healing of chronic venous ulcers in
patients treated in primary care nursing consultations,
measured by the incidence rate of ulcers with complete
healing at 12 weeks of follow-up in each group.
The secondary objectives are to compare the effective-
ness of the multilayer and crepe bandages (based on the
degree of healing achieved and measured with Resvech
2.0), assess improvements in quality of life (measured
with the Charing Cross Venous Ulcer Questionnaire
[CCVuQ-e]) and analyse the sociodemographic, clinical
and treatment factors associated with complete healing
of venous ulcers.
Methods/design
Study design
Randomised, controlled, parallel, multicentre clinical
trial, with 12 weeks of follow-up and blind evaluation of
the response variable.
The study involves 22 primary healthcare centres in the
Madrid region of Spain.: La Paz, Arganda, Artilleros,
Buenos Aires, Federica Montseny, José Maria Llanos,
Pavones, Rafael Alberti, Torito,. Villa de Vallecas,
Villablanca, Villarejo de Salvanés, Mejorada del Campo,
Jaime Vera, Los Alperchines, San Fernando II, Dr.
Tamames, Cerro Almodovar, Ibiza, Valdebernardo,
Vicente Soldevilla and Morata de Tajuña. The last six
centres were added later to the study, in order to achieve
the required number of patients to recruit, being approved
by the Ethics Committee.
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Sixty one volunteer nurses will participate in the study.
The nurses will conduct the intervention.
The investigator will properly inform all study partici-
pants and will request their written, signed and dated in-
formed consent. The investigator will provide complete
and appropriate verbal and written information on the
nature, purpose and potential risks and benefits of their
participation in the study.
Participants
Participants older than 18 years with chronic venous
ulcers who attend to a primary care nursing consultation.
Inclusion criteria
– Over 18 years of age.
– Individuals with a diagnosis of venous ulcers of
more than 6 weeks of evolution. If the participant
has more than one lesion, the nurse will select the
lesion with the highest Resvech score for the study.
– Presence of an ankle brachial index (ABI) greater
than 0.8 and less than 1.3.
– Individuals who able to follow the demands of
the trial and who provide their written informed
consent to participate.
Exclusion criteria
Related to contraindications for compression therapy:
Patients diagnosed with poorly controlled diabetes
mellitus (latest HbA1c according to the recommenda-
tions of American Diabetes Association (ADA) and
European Association for the Study of Diabetes (EASD)
[16]), on treatment with antineoplastic agents, with
decompensated heart failure, acute phase dermatitis, at
the time of the study, rheumatoid arthritis, acute phase
deep vein thrombosis, with mixed ulcers or patients who
are simultaneously participating in another clinical trial.
Sample size
Earlier studies have achieved complete healing rates at
12 weeks of follow-up of 58 % by employing multilayer
bandages. For an alpha error of 0.05 and a beta error of
0.2 (80 % power) and to detect a minimum difference of
20 % between the 2 groups, a total of 97 patients will be
needed in each group. Estimating a 10 % loss rate at
3 months, at least 108 patients will be included in each
study branch.
The patients will be consecutively included in the
study. The recruitment will be competitive until the
sample size is reached.
Random assignment
Randomisation sequence: The randomisation will be per-
formed automatically by inserting the patients’ data into
the electronic case report forms (eCRF).
Lack of knowledge of the randomisation sequence by
the professional who enrols the patients will therefore be
ensured.
Patient recruitment is shown in Fig. 1.
Blinding
It is not possible to blind the intervention in this type of
study. The measurement of the primary endpoint, de-
gree of healing, will be conducted by nurses who are un-
aware of the type of intervention applied to the patient.
The analysis will be performed by practitioners who are
unaware of the assignment.
Intervention
Control group
Standard clinical practice that consists of healing the
wound (assessment, cleaning, disinfection, debridement
and topical treatment) and application of simple com-
pression therapy with a light compression, single-layer
elastic bandage (crepe bandage).
Intervention group
The standard practice in healing will be conducted,
modifying the application of compression therapy, which
in this case will be multilayer, using 2 layers.
All patients will be provided hygienic-dietary counsel-
ling and information on adverse signs and symptoms.
Both interventions will be performed in the health
centre or at home, according to the patient’s needs.
The sequence of visits is listed in Fig. 2.
The schedule of visits is shown in Table 1.
Training
The participant nurses will receive an standardized
training to minimize, as much as possible, the differ-
ences in the in the implementation of the 2 interven-
tions. The method for performing the control technique
will be consistent, and training will be provided to the
nurses participating in the study on multilayer compres-
sion bandages. Both techniques will be documented in
writing and supplemented with images.
To avoid differences in the assessment criteria as
much as possible, prior training will be conducted for
both groups. The blinded evaluators will also be trained.
Variables
Outcome variables
The main outcome variable is the Complete healing at
12 weeks of follow-up: (yes/no). *complete and sustained
epithelialisation for at least 2 weeks. Time elapsed between
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start of the study and complete healing of the wound
(in days).
Secondary outcome variables are: Degree of healing
(Resvech 2.0); health-related quality of life for patients
with venous ulcers (CCVUQ-e) and presence of adverse
reactions.
The RESVECH 2.0 scale was used to monitor wounds
[17]. Based on the results of a PhD thesis, it can be used to
assess characteristics and evaluate the healing process in all
types of chronic wounds. It assesses six parameters: wound
size, depth of the affected tissues, status of the edges, type
of tissue in the wound bed, level of exudate and
inflammation-infection in the wound (presence of biofilm).
The CCVUQe is a specific tool to measure quality of
life with venous ulceration [7], recently validated Spanish
language version of the questionnaire.
Sociodemographic variables
– Age, sex, living alone (yes/no), employment status
and education level.
Variables related to the healing process
– Body mass index. Quantitative (kg/cm2);
underlying disease; ABI; tobacco and alcohol
consumption; topical and systemic treatment;
patient mobility; time dedicated by patient to
walking, exercise and raising the legs above the
heart (minutes/day, times/week); intervention
group.
– Time the patient remains with the legs above the
heart (minutes/week; times/week).
– Intervention group: multilayer compression
bandages with 2 layers / crepe bandages.
Prognostic variables
– Location of the ulcer; number of ulcers at the time
of the study; time in days of evolution of the venous
ulcers before inclusion in the study; recurrent ulcer
(yes/no); location where the intervention is
performed (home/health centre).
NO
NO
YES
NO
YES
NO YES
Agrees to take 
part ? REJECTION
Provide signed 
dated consent
EXCLUSION
Findings 
exclusion criteria
EXCLUSION
Meets exclusion 
criteria
Random assignment (n=216)
2-layer bandages 
(n=108)Crepe bandage 
(n=108)
12-week follow-up
Included in the study: We verified that they meet all 
inclusion criteria and none of the exclusion criteria
Inform about the study
Fig. 1 Patient Recruitment. Patients diagnosed with venous ulcers and who meet the inclusion criteria
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Data collection
During the nursing consultation (in the health centre or
at home), the individuals eligible for inclusion in the
study will be informed of their eligibility and offered a
chance to participate. If they accept, the patients will be
checked to see if they meet all the eligibility criteria and
will be requested to complete and sign the informed
consent. Data collection will be performed every 14 days
during the 12-week follow-up or will finish early if the
ulcer has healed.
The information will be collected through clinical
interviews and wound examinations, and the informa-
tion will be recorded in the eCRFs. We will record those
patients who decline to participate in the study (age and
sex), as well as the losses, attrition and their causes. We
will also record those patients who withdraw due to the
withdrawal criteria.
The researchers will record the severe or unexpected
adverse reactions regarding the product and will notify
the principal investigator.
Lost to follow up
Patients who fail to attend to their appointments will be
contacted by telephone at least twice before they will be
considered lost to follow up. The attrition rate and the
reasons of ‘lost to follow up’ will be specifically collected
during the study.
Assessment 
with Resverch.2
and CCVUQ-e
External nurse 
assessor
Standard and 
experimental 
intervention 
Data collection
Healthcare nurse
1-7 days dressings
Standard and 
experimental 
intervention 
Data collection
Healthcare nurse
1-7 days dressings
Assessment 
with Resverch.2 
and CCVUQ-e
External nurse 
assessor
Standard and 
experimental 
intervention 
Data collection
Healthcare nurse
1-7 days dressings
Assessment 
with 
Resverch.2
External nurse 
assessor
Assessment 
with 
Resverch.2
External nurse 
assessor
Assessment 
with Resverch.2 
and CCQV-e
External nurse 
assessor
Assessment 
with Resverch.2 
and CCQV-e
External nurse 
assessor
Standard and 
experimental 
intervention
Data collection
Healthcare nurse
END OF STUDY
PATIENTS WITH VENOUS 
ULCERS
Initial visit Initial visit
Assessment 
every 2 
weeks
Assessment 
every 2 
weeks
Assessment 
at 3 months
Assessment 
at 3 months
CONTROL GROUP CONTROL GROUPAND 
EXPERIMENTAL
GROUP
EXPERIMENTAL
GROUP
Fig. 2 Sequence of visits in Control and Experimental Group
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Withdrawal criteria
Patients will withdraw from the study if the bandages
cause them adverse reactions that preclude them from
continuing the study or under circumstances that prevent
them from keeping the assigned bandages or performing
the follow-up visits.
Analysis
1. Descriptive analysis of each variable with its
corresponding 95 % confidence interval. Normality
tests. Description of the profile of patients who
withdraw from the study and their reasons for
withdrawal.
2. Comparison of the group at the beginning of the
trial with regard to their descriptive and response
variables and predictors. Bivariate statistical tests
will be employed that are suitable for the variable
type (qualitative or quantitative).
3. Primary effectiveness analysis: A comparison will be
performed of the incidence rates of ulcers with
complete healing, using the ratio of incidence rates,
with their point estimate and 95 % confidence
interval. We will compare the time to complete
healing using Kaplan-Meier curves for both types of
treatment (log-rank test). To adjust for prognostic
factors, we will perform a Cox regression model, with
the time elapsed to complete healing as the dependent
variable, complete healing as the event and the
intervention group as the independent variable. We
will include in the model those variables that can act
as confounding factors or that can modify the effect.
4. Secondary effectiveness analysis: For each secondary
variable, we will apply the appropriate statistical
technique based on the character of each variable
(qualitative or quantitative) and to the distribution
to which they fit (parametric or nonparametric).
The individuals responsible for performing the analysis
will be unaware of which intervention each patient in-
cluded in the study has undergone. All statistical ana-
lyses will be performed by intent-to-treat, using the
conventional level of statistical significance (0.05).
Discussion
The aim of our study is to measure the effectiveness of
an intervention for treating chronic venous ulcers in the
setting of a primary care nursing consultation. Chronic
venous ulcers are a prevalent condition that mainly
affects populations older than 65 years of age. Patients
affected, due to their age and the presence of concomi-
tant diseases, are considered an especially vulnerable
population from a healthcare point of view. This prag-
matically designed clinical trial, conducted in a primary
care setting and that evaluates various nursing interven-
tions, is ultimately aimed at improving the management
of patients with venous ulcers. If the multilayer com-
pression bandages with 2 layers show greater effective-
ness in healing venous ulcers than the crepe bandages
employed in standard practice, the former’s application
in clinical practice will result in better and quicker
healing of these wounds. This in turn will result in
reduced treatment costs, optimising the human and
material resources of the healthcare system. Moreover, it
will contribute to standardising the intervention for
these patients, thereby promoting equal treatment.
Given the nature of the intervention, it is impossible to
blind it. However, we have designed a blind assessment by
nurses who are unaware of the patient assignment, and
the analysis will be performed by professionals who are
also unaware of the assignment.
The patients will be recruited and treated by their own
reference nurses. Although this approach may increase
the variability of the intervention technique, we will try to
minimize it through the prior training to all participant
Table 1 Schedule of visits
Baseline visit
Day 0
Visit 1
Day 1
Visit 2
Day 15
Visit 3
Day 30
Visit 4
Day 45
Visit 5
Day 60
Visit 6
Day 75
Visit 7 Day 90 End
of follow-up
Verification of inclusion criteria x
Patient has signed the informed consent x
Randomisation x
Intervention x x x x x x x
Resverch assessment x x x x x x x
CCVUQ-e questionnaire x x
Collecting data on adverse reactions x x x x x x
Healing complete x x x x x x
Sociodemographic variables x
Prognostic variables x
Variables related to healing x x x x x x x
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nurses. We have also designed a specific eCRFs for data
collection and al the procedures have been standardized.
Although there might be variability in the use of
healthcare products used for healing and therapeutic
adjustment, this variability is minimal, given that the
Primary Care Management implemented an Improve-
ment Plan in 2010 for the Care of Patients with Chronic
Skin Ulcers. The plan provided specific training for
professionals, a design for Recommendations guidelines
[3] and a centralised procurement procedure. The
availability of these products is therefore standardised
and regulated for all health centres.
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223/2004 and according to the procedures established in the instructions for
implementing clinical trials in Spain.
With all of the safety information collected, a periodic report will be
prepared, which will assess the safety of the product employed, taking into
account all available information.
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